In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.

The result was a notable drop in inflammation, with promising results in early models of sepsis and age-related macular degeneration. Related Stories ・Say goodbye to reading glasses: New eye drops are ...

Age-related macular degeneration (AMD) is a leading cause of vision loss among individuals over 65. (CREDIT: CC BY-SA 4.0) The architecture of TIR domains is surprisingly consistent across species.

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Access free, up-to-date clinical references about management strategies for age-related macular degeneration. Healio's Clinical Guidance content provides valuable insights for physicians ...

When to Seek Medical Care for Macular Degeneration For age-related macular degeneration, you should see an eye doctor. They will look at your retina to determine if any treatment is necessary, and ...

Your eye doctor can look for age-related macular degeneration when you see them for a routine eye exam and do a dilated eye exam. An early diagnosis will let you start treatment that may delay ...

What is macular degeneration? Age-related macular degeneration (AMD) is a progressive eye disease primarily affecting your central vision, making it difficult to cook, read, drive, and recognize ...

Dear Savvy Senior, Is macular degeneration hereditary? My mother lost much of her vision from it before she died, and now at age 65, I’m concerned I may get […] ...

Explore information on managing macular degeneration, including treatment options, vision care, and lifestyle changes to maintain eye health and quality of life.

Prevention methods for macular degeneration, a form of central vision loss, include regular monitoring and lifestyle management such as not smoking.